As someone who openly mocks those ads for nasal sprays that help men maintain their erections for longer (can they make one that makes him go faster so I can roll over and go to sleep already?), I can’t imagine myself wanting to use female Viagra any time soon.
That’s not to say I don’t want to improve my sex life, at some stage. Good sex is one of those things that long-term-relationship-types know comes and goes, ebbs and flows, peaks and troughs.
It’s not a priority for me right now, is what I’m trying to say (no offence, hon). There are those that say sex should always be a priority. Which is why there has been so much anticipation for the female version of Viagra that has just been approved by the Food and Drug Administration (FDA) in the U.S.
However, so far, reviews of the “little pink pill” are mixed.
Known as flibanserin but marketed as Addyi, it is designed for women suffering from Hypoactive Sexual Desire Disorder (HSDD) which is defined by the manufacturers as, “women who have not gone through menopause, who have not had problems with low sexual desire in the past, and who have low sexual desire no matter the type of sexual activity, the situation, or the sexual partner.”
It is NOT for women with:
- a medical or mental health problem;
- problems in the relationship;
- medicine or other drug use.
Or (added by me, not the manufacturer):
- those who don’t have time for good sex;
- the sleep-deprived.
Look, I shouldn’t make light of it. There were high hopes for female Viagra. Sadly, many women have been left disappointed. Researchers in the Netherlands ran a study of female Viagra and published the results in JAMA Internal Medicine, where they found limited effectiveness and side effects such as dizziness, sleepiness and nausea. Dr. Steven Woloshin and Dr. Lisa Schwartz also questioned the product’s safety.
“The FDA approved a marginally effective drug for a non-life-threatening condition in the face of substantial — and unnecessary — uncertainty about its dangers.”